This validated previous investigation revealed lower amounts of IFN-α in hospitalized COVID-19 patients versus controls [63] and in severely ill COVID-19 individuals versus mild-moderate COVID-19 patients [62,64]. This evidence concerns the gene IFNA17 and COVID-19.